Inventor
KEN MUKAI
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds20%
A61KPreparations for medical, dental or toiletry purposes8%
C07KPeptides8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
B82YSpecific uses or applications of nanostructures4%
C01BNon-metallic elements4%
C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds4%
D01FChemical features in the manufacture of artificial filaments, threads, fibres, bristles or ribbons4%
PatentTitleYear
12,312,331Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors202512,030,883Hetero-tricyclic compounds as inhibitors of KRAS202411,686,019Fiber constituted from carbon nanotube and method for manufacturing same202311,447,494Tricyclic amine compounds as CDK2 inhibitors202211,440,914Tricyclic amine compounds as CDK2 inhibitors202211,427,567Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to INCYTE CORP (5)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to AIST (1)· patent assignee history
2023Patents assigned to ASAHI CHEMICAL IND (1)· patent assignee history
2023Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 5 | 2022–2025 |
| AIST | 1 | 2023 |
| ASAHI CHEMICAL IND | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |
| JP | 1 | 2023 |